Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study

Podobne zapisy

• Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50
  od: Lilja, Hans, i wsp.
  Wydane: (2010)
• Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
  od: Vickers, Andrew J, i wsp.
  Wydane: (2013)
• A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening
  od: Vickers, Andrew, i wsp.
  Wydane: (2010)
• Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
  od: Klein, Robert J., i wsp.
  Wydane: (2011)
• Anthropometric measures at multiple times throughout life and prostate cancer diagnosis, metastasis and death
  od: Gerdtsson, A., i wsp.
  Wydane: (2015)